Capstone Investment Advisors
RMD icon

Capstone Investment Advisors’s ResMed RMD Stock Holding History

Capstone Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$575K Sell
2,563
-162
-6% -$40.4K ﹤0.01% 1080
2025
Q4 		$656K Buy
+2,725
New +$697K ﹤0.01% 1039
2025
Q3 		– Sell
-1,421
Closed -$388K – 2039
2025
Q2 		$367K Buy
+1,421
New +$339K ﹤0.01% 1290
2025
Q1 		– Sell
-3,314
Closed -$774K – 1788
2024
Q4 		$758K Buy
3,314
+1,894
+133% +$456K ﹤0.01% 1160
2024
Q3 		$347K Sell
1,420
-1,413
-50% -$316K ﹤0.01% 1349
2024
Q2 		$542K Sell
2,833
-2,159
-43% -$438K ﹤0.01% 1265
2024
Q1 		$989K Buy
4,992
+1,999
+67% +$366K ﹤0.01% 1159
2023
Q4 		$515K Buy
2,993
+1,654
+124% +$254K ﹤0.01% 1329
2023
Q3 		$198K Buy
1,339
+1,326
+10,200% +$240K ﹤0.01% 1818
2023
Q2 		$2.84K Buy
+13
New +$2.9K ﹤0.01% 1820
2023
Q1 		– Sell
-662
Closed -$138K – 1662
2022
Q4 		$138K Sell
662
-4,213
-86% -$926K ﹤0.01% 1356
2022
Q3 		$1.06M Buy
+4,875
New +$1.11M 0.01% 981
2022
Q1 		– Sell
-1
Closed -$242 – 2139
2021
Q4 		$0 Sell
1
-8,086
-100% -$2.1M ﹤0.01% 2057
2021
Q3 		$2.13M Buy
+8,087
New +$2.21M ﹤0.01% 1168
2019
Q2 		– Sell
-91
Closed -$10.1K – 1428
2019
Q1 		$9K Buy
+91
New +$9.39K ﹤0.01% 1263
2017
Q2 		– Sell
-30,299
Closed -$2.18M – 884
2017
Q1 		$2.18M Buy
30,299
+15,983
+112% +$1.1M 0.05% 267
2016
Q4 		$888K Sell
14,316
-21,584
-60% -$1.32M 0.03% 456
2016
Q3 		$2.33M Buy
+35,900
New +$2.39M 0.05% 237
2016
Q2 		– Sell
-35,963
Closed -$2.08M – 825
2016
Q1 		$2.08M Buy
35,963
+23,207
+182% +$1.31M 0.06% 181
2015
Q4 		$684K Buy
+12,756
New +$719K 0.02% 301

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capstone Investment Advisors's RMD Position: Q1 2026 in Review

Capstone Investment Advisors reduced its ResMed (RMD) stake by 5.9% in Q1 2026, selling an estimated $40.4K and leaving 2,563 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

Capstone Investment Advisors first reported a position in RMD in Q4 2015 and has held it in 20 quarters since. The position peaked at $2.33M in Q3 2016. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Capstone Investment Advisors held 2,563 shares of ResMed worth $575K as of Q1 2026.
  • Capstone Investment Advisors sold 162 ResMed shares in Q1 2026, an estimated $40.4K.
  • ResMed made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1080 holding.
  • Capstone Investment Advisors first reported a position in ResMed in Q4 2015 and has held it in 20 quarters since.
  • Capstone Investment Advisors's ResMed position peaked at $2.33M in Q3 2016.
  • 941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.